COVID-19 Predeparture Test Results and Vaccination Coverage among US-Bound Refugees, 2020–2022

IF 6.6 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2025-07-16 DOI:10.3201/eid3108.250088

Ashley S. Judge, Tarissa Mitchell, Alexander Klosovsky, Michelle Weinberg, Christina R. Phares

引用次数: 0

Abstract

We describe predeparture COVID-19 test positivity and vaccination coverage for US-bound refugees. During November 24, 2020–June 11, 2022, a total of 23,972 refugees received 28,465 tests (87% reverse transcription PCR); 2.6% of refugees tested positive. During November 24, 2020–December 31, 2022, vaccination coverage rose from 0% to 71% among 24,831 adult refugees.

查看原文本刊更多论文

2020-2022年赴美难民COVID-19出境前检测结果和疫苗接种覆盖率

我们描述了前往美国的难民出发前COVID-19检测阳性和疫苗接种覆盖率。在2020年11月24日至2022年6月11日期间，共有23,972名难民接受了28,465次检测（87%逆转录PCR）；2.6%的难民检测呈阳性。在2020年11月24日至2022年12月31日期间，24,831名成年难民的疫苗接种覆盖率从0%上升到71%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.